QuikReader

QuikReader

  • Latest
  • Top stories
  • Business
  • Tech
  • World
  • Politics
  • Sports
  • Lifestyle
  • Health
  • Science
  • Entertainment
  • More
    • Sources
Sign in

Latest in Eli Lilly shares jump on two big updates and Jim Cramer is so here for it

Sort by
3,379 items

  • Eli Lilly shares jump on two big updates and Jim Cramer is so here for it

    The Biden administration proposed a rule change that would expand access to Eli Lilly's Zepbound. And an obesity drug competitor released disappointing results.
    Business - CNBC - 15 hours ago

  • Jim Cramer identifies an interesting buy level for our worst performing Big Tech stock this year

    The Investing Club holds its "Morning Meeting" every weekday at 10:20 a.m. ET.
    Business - CNBC - October 31

  • Jim Cramer's big takeaway from the market reaction to Nvidia's earnings beat

    The Investing Club holds its "Morning Meeting" every weekday at 10:20 a.m. ET.
    Business - CNBC - 5 days ago
  • Shares in weight-loss drugmaker Eli Lilly fall on disappointing sales

    Shares in weight-loss drugmaker Eli Lilly fall on disappointing sales

    US group revises down upper end of full-year revenue estimates
    Business - Financial Times - October 30

  • Best Buy rallies ahead earnings, Black Friday — but here's why we're still cautious

    The Investing Club holds its "Morning Meeting" every weekday at 10:20 a.m. ET.
    Business - CNBC - Yesterday

  • Eli Lilly's Zepbound and Mounjaro are no longer in shortage. Here's where their sales still disappointed

    Eli Lilly blamed the misses on drug wholesalers cutting inventory of Zepbound and Mounjaro.
    Business - CNBC - October 30

  • Here's why Eli Lilly bounced back, plus mega-caps lag while staples stocks rise

    Every weekday, the Investing Club releases the Homestretch; an actionable afternoon update just in time for the last hour of trading.
    Business - CNBC - November 8

  • Cramer says 'so many things are working' in the market. Here are a few bright spots

    The Investing Club holds its "Morning Meeting" every weekday at 10:20 a.m. ET.
    Business - CNBC - November 8

  • Team Meta? Team Alphabet? A noted tech analyst weighs in and so does Jim Cramer

    Cramer sees merit in MoffettNathanson's buy calls on Alphabet and Meta.
    Business - CNBC - November 12

  • Jim Cramer reviews ten stocks that are up more than 200% so far this year

    CNBC's Jim Cramer on Wednesday reviewed ten stocks worth more than $1 billion that have run up big this year, including Cava, Palantir and Carvana.
    Business - CNBC - November 13

  • Jim Cramer wants to buy more shares of 2 portfolio companies with favorable catalysts

    The Investing Club holds its "Morning Meeting" every weekday at 10:20 a.m. ET.
    Business - CNBC - October 28

  • Analysts are conflicted on industrials — and why we disagree with a sell call on Starbucks

    The Investing Club holds its "Morning Meeting" every weekday at 10:20 a.m. ET.
    Business - CNBC - November 13

  • Disney's comeback has another believer. What Jim Cramer says to do with the stock from here

    Another Wall Street firm sees progress in Disney's turnaround.
    Business - CNBC - November 18

  • Jim Cramer says he's feeling even more confident in Apple's future. Here's why

    Bernstein's Toni Sacconaghi laid out a clear path for Apple shares to climb higher.
    Business - CNBC - 6 days ago

  • Jim Cramer ascribes market rally to Trump's victory and pro-big business policies

    CNBC's Jim Cramer reviewed Wednesday's market action.
    Business - CNBC - November 7

  • Lilly’s Mounjaro, Zepbound drugs see strong demand. So why did sales disappoint?

    Eli Lilly’s stock heads for biggest selloff in more than three years after sales of anti-obesity drugs Mounjaro and Zepbound came up well short of forecasts.
    Business - MarketWatch - October 30

  • Eli Lilly's quarter was messy. What to do with the stock is more clear-cut

    We're upgrading our rating on the drugmaker to a buy-equivalent 1.
    Business - CNBC - October 30

  • Healthy Returns: Eli Lilly’s cholesterol pill impresses in mid-stage trial

    Eli Lilly’s cholesterol pill impressed in a mid-stage trial. Meanwhile, Dexcom invested $75 million in Oura.
    Business - CNBC - November 19

  • Jim Cramer warns of market 'excess' as stocks surge

    CNBC's Jim Cramer on Monday described signs of "excess" he sees across market sectors.
    Business - CNBC - Yesterday

  • Eli Lilly stock tumbles after drug giant misses estimates and slashes profit guidance

    Skyrocketing demand for weight loss and diabetes drugs has forced Eli Lilly and Novo Nordisk, to invest billions to increase manufacturing capacity.
    Business - CNBC - October 30

  • How we're thinking about Eli Lilly after Trump picked obesity-drug critic RFK Jr. to run HHS

    Robert F. Kennedy Jr. has been a vocal critic of obesity drugs belonging to the fast-growing GLP-1 class.
    Business - CNBC - November 15

  • Home Depot is both a secular and cyclical stock, Jim Cramer says

    CNBC's Jim Cramer on Monday suggested that Home Depot is able to both grow independently of the business cycle and flourish when the economy is doing well.
    Business - CNBC - October 29

  • Jim Cramer's top 10 things to watch in the stock market Tuesday

    Stocks were headed for a muted open after a solid session Monday.
    Business - CNBC - October 29

  • Jim Cramer's top 10 things to watch in the stock market Thursday

    The Fed's favorite inflation gauge also matched expectations.
    Business - CNBC - October 31

  • Don't be alarmed by conservative guidance after a solid quarter, Jim Cramer says

    CNBC's Jim Cramer on Thursday told investors not to get scared off when a company posts good earnings results but issues more modest guidance.
    Business - CNBC - October 31

  • Jim Cramer's top 10 things to watch in the stock market Friday

    Stocks looked to rebound to start November after a tough trading session.
    Business - CNBC - November 1

  • Cramer raves about Salesforce's star-powered plan to raise awareness of its new AI agents

    The Investing Club holds its "Morning Meeting" every weekday at 10:20 a.m. ET.
    Business - CNBC - November 4

  • Jim Cramer's top 10 things to watch in the stock market Friday

    The S&P 500 and Dow were on track for muted opens Friday after big advances in response to Donald Trump's presidential victory.
    Business - CNBC - November 8

  • Jim Cramer's top 10 things to watch in the stock market Tuesday

    Wall Street was taking a breather early Tuesday after the S&P 500 extended its record-breaking post-election rally.
    Business - CNBC - November 12

  • Jim Cramer's top 10 things to watch in the stock market Wednesday

    Inflation and the Fed are key to markets. But what about Donald Trump's new regime?
    Business - CNBC - November 13
  • 1
  • 2
  • 3
  • »
  Follow topic
Topics
  • Eli Lilly Shares
  • Lilly Shares Jump
  • Shares Jump Two
  • Jump Two Big
  • Two Big Updates
© 2024 QuikReader - About - Terms - Privacy